What does this research mean for the field?

Omega-3 fatty acids do not outperform placebo as adjunct therapy for pediatric depression in youths with major depressive disorder. Novelty: ClaimNovelty.CONTRADICTORY. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

What question did this study set out to answer?

The aim is to evaluate the effectiveness of omega-3 fatty acids as an adjunct therapy for pediatric depression.

March 13, 2026The Brown University Child and Adolescent Behavior Letter0 citations

RCT: Omega‐3 fatty acids not supported as adjunct therapy for pediatric depression

View Full Paper

AKAlison Knopf

Key Points

The aim is to evaluate the effectiveness of omega-3 fatty acids as an adjunct therapy for pediatric depression.
Randomized controlled trial comparing omega-3 fatty acids to placebo
Focus on youths diagnosed with major depressive disorder
Assessment of therapy's effectiveness alongside antidepressants
Omega-3 fatty acids did not show improved outcomes compared to placebo
No significant difference in symptoms of depression was observed

Abstract

Researchers have found that omega‐3 fatty acids such as eicos‐apentaenoic acid (EPA) and docosahexaenoic acid (DHA), as an adjunct to antidepressants, do not outperform placebo in youths with major depressive disorder.

KI fragen

Bookmark

View Full Paper

KI fragen

Bookmark

View Full Paper

RCT: Omega‐3 fatty acids not supported as adjunct therapy for pediatric depression

Key Points

Abstract

Cite This Study

Also Consider

Also Consider